Alpha-Lipoic Acid: What the Evidence Actually Says

What is alpha-lipoic acid?

Alpha-lipoic acid (ALA) is a naturally occurring organosulphur compound synthesised in small amounts by the body and found in trace quantities in foods such as spinach, broccoli, and organ meats. It acts as a cofactor for mitochondrial enzymes involved in energy metabolism and functions as both a fat- and water-soluble antioxidant — a dual solubility that sets it apart from vitamins C and E.

The supplement comes in two forms: the biologically active R-ALA isomer (the form the body makes) and the cheaper racemic RS-ALA blend (roughly 50% R, 50% inert S). Most clinical trials used the racemic form at 600 mg/day, but R-ALA achieves higher plasma concentrations at equivalent doses and is the smarter buy if cost allows.

Does it work? The evidence

Diabetic neuropathy — Grade B

The strongest case for ALA sits in neuropathy. The ALADIN (Alpha-Lipoic Acid in Diabetic Neuropathy) trial (Ziegler et al., 1995, Diabetologia) and the SYDNEY 2 trial (Ziegler et al., 2006, Diabetes Care) used intravenous and oral ALA (600 mg/day racemic) in patients with diabetic peripheral neuropathy and found meaningful reductions in the Total Symptom Score — covering pain, burning, paraesthesia, and numbness — versus placebo. This is Grade B evidence: multiple controlled trials with consistent directional findings, though most are sponsored and the patient population is specific. ALA is not a drug; it does not reverse structural nerve damage, but symptom relief at 600 mg/day is clinically plausible and the evidence base is real.

Glucose and insulin sensitivity — Grade C

Controlled trials show ALA can modestly reduce fasting glucose and improve insulin-stimulated glucose uptake, likely via AMP-activated protein kinase (AMPK) activation — a mechanism shared with metformin. The effect sizes are small in otherwise healthy or mildly insulin-resistant adults. This is Grade C: real signal, limited and mixed evidence, modest magnitude. It is not a substitute for dietary intervention, progressive exercise, or prescribed medication.

Body weight — Grade C

A handful of trials report modest weight reductions (typically 1–3 kg over 8–24 weeks) compared to placebo, possibly related to reduced appetite and improved glucose disposal. The effect is too small and inconsistently replicated to recommend ALA as a weight-loss supplement in isolation. Grade C — situational at best.

How to take it

The evidence-backed dose is 300–600 mg/day of racemic RS-ALA. R-ALA is better absorbed, so a proportionally lower dose achieves comparable plasma concentrations — check the product label to confirm which isomer you are buying. Take it on an empty stomach — a co-ingested meal reduces peak plasma concentration by approximately 30%. For doses above 300 mg, split into two doses (morning and mid-afternoon) to reduce GI side effects and maintain steadier plasma levels.

Trials on neuropathy typically run for 3–6 months before meaningful symptom response is assessed. Do not expect rapid results.

If you are using ALA specifically to explore glucose management, pair it with a calorie target and a structured nutrition approach — the supplement cannot outwork a poor diet.

Who should take it — and who shouldn't

Potentially relevant for:

• Adults with diabetic peripheral neuropathy, under GP supervision.
• Individuals with confirmed insulin resistance or metabolic syndrome exploring adjunct support alongside lifestyle change.
• Those with high oxidative stress burdens (poor diet, sedentary lifestyle, heavy alcohol use) — though food and exercise address root causes far more effectively.

Avoid or use only under medical supervision if you:

• Take insulin, metformin, sulphonylureas, or any other glucose-lowering medication — the hypoglycaemia risk is real and potentially serious.
• Have known or suspected thiamine (vitamin B1) deficiency — ALA can worsen this by interfering with thiamine-dependent enzymes at high doses.
• Take thyroid medication (levothyroxine) — ALA may reduce absorption; separate by at least 4 hours or discuss with your prescriber.
• Are pregnant or breastfeeding — no adequate safety data exists.
• Are under 18.

For most recreational lifters and general-fitness trainees — unless you have a metabolic condition — ALA is not a priority. Your training, protein intake, and sleep quality will do far more. If you want to know exactly where supplements fit your programme, book a free consultation.

Safety and interactions

The most clinically important safety concern is hypoglycaemia. ALA has insulin-sensitising effects that are additive with glucose-lowering drugs. Blood glucose should be monitored closely if combining with any diabetes medication.

A rare but documented adverse effect is insulin autoimmune syndrome (IAS), in which ALA triggers antibody production against endogenous insulin, causing unpredictable hypoglycaemia. Reported cases are more common in Asian populations and typically involve doses above 600 mg/day.

Long-term high-dose use may deplete thiamine (vitamin B1) — consider a B-complex supplement if using ALA for more than 8 weeks.

Common side effects at typical doses include nausea, stomach cramps, and reflux — particularly when taken in isolation without food despite the absorption trade-off. Start at 300 mg and assess tolerance before increasing.

General information, not medical advice — check with a GP or pharmacist before starting, especially if pregnant, breastfeeding, under 18, or on medication.

How to buy it well

R-ALA is more expensive but worth the premium for bioavailability if budget allows. Look for products that declare the isomer clearly on the label — generic "ALA" is almost always the racemic mix. Avoid blends that bury ALA in a proprietary stack alongside stimulants or undisclosed doses.

For a metabolic supplement carrying real drug-interaction risk, third-party testing for identity and heavy metals is non-negotiable. Look for products certified by a recognised testing body (Informed-Sport or equivalent) and with a certificate of analysis (COA) available on request. Botanicals and mitochondrial supplements are a common vector for contamination — verify before buying.

Given the drug-interaction profile, buying cheap, unverified ALA to self-experiment without a clear indication is not a smart risk.

The verdict

Alpha-lipoic acid is situational — Grade C overall, with a meaningful Grade B carve-out for diabetic neuropathy under medical guidance. For the general fitness population, it is not a priority purchase. If you have metabolic syndrome, confirmed insulin resistance, or neuropathic symptoms, it may be worth discussing with your GP or a qualified dietitian as an adjunct to a structured programme.

For everyone else: the 95% of results comes from progressive training, sufficient protein (check with the protein calculator), quality sleep, and consistency. Supplements are the last 5%.

If you want a coaching plan that sequences your nutrition, training, and supplement stack in order of actual impact, book a free consultation — or start with the free Blueprint quiz to see where you stand right now.